MQ02-439

MQ02-439
Clinical data
Other names1-Methoxynoraporphine; Compound 18b
Drug classSerotonin 5-HT2C receptor agonist
ATC code
  • None
Identifiers
  • 1-methoxy-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC17H17NO
Molar mass251.329 g·mol−1
3D model (JSmol)
  • COC1=C2C3=CC=CC=C3CC4C2=C(CCN4)C=C1
  • InChI=1S/C17H17NO/c1-19-15-7-6-11-8-9-18-14-10-12-4-2-3-5-13(12)17(15)16(11)14/h2-7,14,18H,8-10H2,1H3
  • Key:MHHVBPCYYCUVPT-UHFFFAOYSA-N

MQ02-439, also known as 1-methoxynoraporphine, is a serotonin 5-HT2C receptor agonist of the noraporphine family. It is a potent and selective full agonist of the serotonin 5-HT2C receptor, with an EC50Tooltip half-maximal effective concentration (EmaxTooltip maximal efficacy) of 103 nM (96%). The drug showed no activation of the serotonin 5-HT2A and 5-HT2C receptors at concentrations of up to 10,000 nM. However, it did show weak antagonism of these two receptors. The chemical synthesis of MQ02-439 has been described. Various analogues of MQ02-439 have also been described, including some with potent serotonin 5-HT2A receptor agonist activity. The (S)- enantiomer of MQ02-439 is known as MQ02-592 and is the more potent enantiomer in terms of serotonin 5-HT2C receptor agonism. MQ02-439 was described in the scientific literature by Qi Mao and colleagues in 2020.